Kidney Stone Management Market (By Type of Stone: Calcium oxalate, Calcium phosphate, Uric acid, Cysteine, struvite; By Diagnostics Method: Abdominal X-Ray, Computed Tomography, Ultrasound, Abdominal MRI, Intravenous Pyelography, Others; By Treatment: Extracorporeal Shock Wave Lithotripsy ESWL, Ureteroscopy, Percutaneous Nephrolithotomy PCNL, Others; By End use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global kidney stone management market size was estimated at USD 2.73 billion in 2023 and is predicted to hit around USD 4.65 billion by 2033, growing at a CAGR of 5.47% from 2024 to 2033. Rising cases of kidney stones worldwide due to the modern sedentary lifestyle and excessive intake of minerals and salt-based diet among the population are major drivers of the market globally.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The kidney stone management market is witnessing significant growth due to the rising prevalence of kidney stones worldwide. A kidney stone is also known as renal calculus.it is a complex, crystalline mineral material formed within the kidney or urinary tract. These stones can cause severe pain and discomfort, which has led to an increased demand for effective and innovative solutions for kidney stone management.
Despite the availability of advanced treatment options, the high costs associated with kidney stone management procedures can be a highly impeding market restraint. The expenses involved in surgeries, hospital stays, and post-operative care can financially burden patients, particularly in developing countries with limited healthcare resources.
The kidney stone management market is driven by factors such as the increasing prevalence of kidney stones, advancements in medical technology, and the aging population. However, high treatment costs and a need for more awareness act as restraints on market growth. Opportunities exist in the demand for non-invasive procedures, the adoption of ESWL, and technological advancements in stone retrieval devices. As the global burden of kidney stones continues to rise, the market is poised for further growth and innovation in the coming years.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 5.47% |
Global Market Size in 2023 | USD 2.73 Billion |
Global Market Size by 2033 | USD 4.65 Billion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Type of Stone, By Diagnostics Method, By Treatment, and By End-use |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: Increasing prevalence of kidney stone
The primary driver for the kidney stone management market is the growing prevalence of kidney stones globally. Factors such as a sedentary lifestyle, poor diet choices, and increased obesity rates have contributed to the rise in kidney stone cases. The increasing number of patients seeking medical intervention to manage kidney stones has created a growing market for innovative and efficient treatment options.
The global aging population is another significant reason for the kidney stone management market. Older individuals are more susceptible to developing kidney stones due to age-related kidney and urinary system changes. The increasing number of elderly individuals worldwide is expected to drive the demand for kidney stone management solutions.
Restraint: Lack of awareness among the population
A major restraint for the kidney stone management market is the need for more awareness about kidney stones and their management. Many individuals may need to be aware of the symptoms, risk factors, and available treatment options. This leads to delayed diagnosis and treatment, affecting market growth. Educational campaigns and awareness programs are essential to overcome this restraint and improve patient outcomes.
Opportunity: Growing demand for non-invasive medical procedures
There is a growing demand for non-invasive or minimally invasive procedures for kidney stone management. These procedures offer several advantages over traditional open surgeries, such as reduced pain, shorter hospital stays, and faster recovery times. Innovative techniques like laser lithotripsy, percutaneous nephrolithotomy (PCNL), and robotic-assisted surgeries provide immense opportunities for market growth.
ESWL is a well-established method for kidney stone management and is widely adopted globally. This non-invasive procedure uses shock waves to break down kidney stones into smaller pieces, making them easier to pass through urine. The increasing adoption of ESWL, especially in developing countries, presents significant growth opportunities for the kidney stone management market.
The calcium oxalate segment held the largest share in the market in 2023. Hence, kidney stone management mainly consists of calcium oxalate. Followed by struvite, uric acid, and cysteine-type stones, nearly 75% of kidney stones are formed by calcium oxalate deposition. A diet with higher levels of sugar, oxalate, and protein is the primary reason for a kidney stone of oxalate.
The risk factors that come along with such a type of kidney stone are obesity, cardiovascular triggers, and other underdiagnosed medical conditions that could lead to an exacerbation of kidney disease. The rising prevalence of digestive disorders due to the sedentary lifestyle of modern days comes with fat saturation on the main functioning body parts among the population, which is the driver of the kidney stone management market—and stimulating its further growth on a global scale.
The ultrasound segment held a significant share in the market in 2023. Ultrasound is a widely used imaging method to diagnose kidney stones, followed by abdominal MRI, X-RAY, and computed tomography methods. As the name suggests, ultra-sound is a method where sound waves are used to detect kidney stones without exposure to radiation that might be harmful to the human system.
Ultrasound is the only method considered safe for young people and pregnant ladies, and the European Association of Urology also recommends it as a first-line diagnostic technology. That's why many radiologists preferentially use an ultrasound method, which drives the market. Additionally, this technology can be safely used on children precisely due to their small body structure. Eventually, ultrasound will be the segment driving the kidney stone management market with considerable shareholdings on a broader scale, stimulating the further expansion of the market across various regions.
The extracorporeal shock wave lithotripsy ESWL segment held the largest share of 59% in 2023 and dominated the kidney stone management market globally. ESWL holds the largest market share due to its non-invasive nature and wide availability. They are making it a preferred choice of physicians for treating kidney stones. The procedure involves using shock waves to break down the stones into smaller fragments, which are then passed out of the body through urine. Extracorporeal shock wave lithotripsy uses generated acoustic or sound waves which damage stones due to the effects of direct stresses and cavitation done on the target area.
Generally, ESWL treatment is less painful than conventional surgeries that require anesthesia before procedure. These devices are being modified to generating a pulses of shock wave from electromagnetic and piezoelectric sources to break down a stone with immensely focused intensity. Hence, ESWL's effectiveness, minimal complications, and shorter recovery times contribute to its prominence in the market.
The hospitals segment held the largest market share and dominated the kidney stone management market. The market is divided by end-users, including hospitals, specialty clinics, ambulatory surgical centers, and others. This segment is witnessing a rise in kidney stone patients and hospitals adopting advanced technology. Hospitals provide satisfactory reimbursement to patients. That is also another major driver of growth in this segment.
After the hospital segment, the specialty clinics segment is expected to experience the highest growth rate over the forecast period. They are currently the fastest-growing segment in the global market, followed by the hospitals segment. The specialty clinics segment will see a rise in skilled surgeons and favorable reimbursement policies available for patients.
North America dominated the kidney stone management market globally in the previous year of 2022, and it is poised to hold its position in the market at a considerable pace to reach up to 1.6 billion by 2033. The region is popular for its novel technologies and research centers with world-class medical facilities, institutions, and effective procedures to remove kidney stones with minimal invasion in the human system, leading to lesser damage of healthy cells in the body that would not be achievable otherwise by conventional surgery practices by professionals. Country-wise, unites states has an exceptionally advanced healthcare system facilitated by a robust infrastructure.
The US has pharmaceutical companies that are highly engaging in the research and development of cutting-edge technologies that can be integrated with the healthcare system to reduce the possible improved diagnostic tools effectiveness and outcome of kidney stone removal procedures can be enhanced. Consequently, healthcare providers acknowledge this rising demand and have started offering a wide range of customized services with advanced treatments, which is attracting patients to the North American healthcare system and further driving the growth of the kidney stone management market on a global level.
Asia Pacific is an expanding market, and it is projected to hold the largest share of the kidney stone management market, with an estimated revenue share of 36% by the end of 2033. The geriatric population and age-related health concerns, including kidney-related dysfunctionalities, are prominent drivers of the Asia Pacific market. Such a rising trend increases the demand for effective management strategies fabricated with the particular needs of individuals suffering from kidney diseases, which could be fatal in the long run.
Technological advancements play an essential role in driving the Asian Pacific market. The region has numerous innovative technologies that offer precise and effective treatment. The integration of robotic assistance with advanced tools is crucial to managing kidney stone procedures and enhancing the capabilities of the healthcare sector.
Segments Covered in the Report
By Type of Stone
By Diagnostics Method
By Treatment
By End-use
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Kidney Stone Management Market
5.1. COVID-19 Landscape: Kidney Stone Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Kidney Stone Management Market, By Type of Stone
8.1. Kidney Stone Management Market, by Type of Stone, 2024-2033
8.1.1. Calcium oxalate
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Calcium phosphate
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Uric acid
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Cysteine
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. struvite
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Kidney Stone Management Market, By Diagnostics Method
9.1. Kidney Stone Management Market, by Diagnostics Method, 2024-2033
9.1.1. Abdominal X-Ray
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Computed Tomography
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Ultrasound
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Abdominal MRI
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Intravenous Pyelography
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Kidney Stone Management Market, By Treatment
10.1. Kidney Stone Management Market, by Treatment, 2024-2033
10.1.1. Extracorporeal Shock Wave Lithotripsy ESWL
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Ureteroscopy
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Percutaneous Nephrolithotomy PCNL
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Kidney Stone Management Market, By End-use
11.1. Kidney Stone Management Market, by End-use, 2024-2033
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Specialty Clinics
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Ambulatory Surgical Centres
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Other
11.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Kidney Stone Management Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.1.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.1.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.1.4. Market Revenue and Forecast, by End-use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.2.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.2.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.2.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.3.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.3.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.3.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.4.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.4.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.4.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.5.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Treatment (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 13. Company Profiles
13.1. Cook Medical Inc. (US)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Boston Scientific Corporation (U.S.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Olympus Corp. (Japan)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. C.R. Bard Inc. (U.S.)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Storz Medical AG (Switzerland)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Richard Wolf GmbH (Germany)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Lumenis (Israel)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. EDAP TMS (France)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. DirexGroup (Germany)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Elmed Electronics & Medical Industry & Trade Inc. (Turkey)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client